VEGFR2-targeted fusion antibody improved NK cell-mediated immunosurveillance against K562 cells.

about

Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer.

P2860

Q44645655-3AAB84B0-06C2-41F4-8A68-537126224009

P2860

VEGFR2-targeted fusion antibody improved NK cell-mediated immunosurveillance against K562 cells.

Item

http://www.wikidata.org/entity/Q39787455

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

VEGFR2-targeted fusion antibod ...... rveillance against K562 cells.

@en

VEGFR2-targeted fusion antibod ...... rveillance against K562 cells.

@nl

type

Item

label

VEGFR2-targeted fusion antibod ...... rveillance against K562 cells.

@en

VEGFR2-targeted fusion antibod ...... rveillance against K562 cells.

@nl

prefLabel

VEGFR2-targeted fusion antibod ...... rveillance against K562 cells.

@en

VEGFR2-targeted fusion antibod ...... rveillance against K562 cells.

@nl

P1476

VEGFR2-targeted fusion antibod ...... rveillance against K562 cells.

@en

P2093

Chenchen Li

http://www.w3.org/2001/XMLSchema#string

Fang Liu

http://www.w3.org/2001/XMLSchema#string

Juan Zhang

http://www.w3.org/2001/XMLSchema#string

Menghuai Xu

http://www.w3.org/2001/XMLSchema#string

Min Wang

http://www.w3.org/2001/XMLSchema#string

Mingying Tang

http://www.w3.org/2001/XMLSchema#string

Wei Xie

http://www.w3.org/2001/XMLSchema#string

Xueyan Ren

http://www.w3.org/2001/XMLSchema#string

Youfu Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids.

NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma

Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion.

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias

Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays.

Clinical and biological predictors of outcome following relapse of CML post-allo-SCT

Soluble ligands for the NKG2D receptor are released during endometriosis and correlate with disease severity.

Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity.

Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis.

NKG2D Receptor and Its Ligands in Host Defense

P2888

s12026-016-8800-3

P31

scholarly article

P356

10.1007/S12026-016-8800-3

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27154226

http://www.w3.org/2001/XMLSchema#string

VEGFR2-targeted fusion antibody improved NK cell-mediated immunosurveillance against K562 cells.

about

P2860

P2860

VEGFR2-targeted fusion antibody improved NK cell-mediated immunosurveillance against K562 cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P698